Together, these data indicate that the therapy-elicited effector T cells, identified by the activation markers CD431B11, NKG2A, and KLRG1, are characterized by dynamic expansion/contraction kinetics resembling those of vaccine- or infection-provoked T cell responses. This evidence concerns the gene KLRG1 and infection.